Protocol of a randomised controlled phase II clinical trial investigating PREoperative endoscopic injection of BOTulinum toxin into the sphincter of Oddi to reduce bile leakage after hepatic resection: the PREBOT-II trial
C. Mack(Heidelberg University), Thilo Hackert(Universität Hamburg), Lukas Baumann(Statistics Austria), Markus W. Büchler(Heidelberg University), Ulla Klaiber(Vienna General Hospital), Laura Kohlhas(Heidelberg University), Peter Sauer(Heidelberg University), Eike Martin(Heidelberg University), Arianeb Mehrabi(Heidelberg University)
Cited by 1
Related Papers
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Bile leakage after hepatobiliary and pancreatic surgery: A definition and grading of severity by the International Study Group of Liver Surgery
|Surgery|2011|1.9k
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|The Lancet|2017|1.9k